John Shaughnessy Jr
Title | Professor |
---|
Institution | University of Arkansas for Medical Sciences |
---|
Department | Internal Med, College of Medicine |
---|
Division | Internal Med Hem-Onc |
---|
Address | 4104 Outpatient Circle Mail Slot # 508 Little Rock AR 72205
|
---|
Phone | 501-526-6990 |
---|
ORCID
.gif) | 0000-0002-2017-6236  |
---|
vCard | Download vCard |
---|
|
|
|
Research 1U54CA272691 (ZHAN, FENGHUANG)Sep 1, 2023 - Aug 31, 2027 NIH/Nat. Cancer Institute - Pass Through: Baylor College of Medicine U54 - Administrative Core Role: Principal Investigator |
| 1U54CA272691-01A1 (ZHAN, FENGHUANG)Sep 1, 2023 - Aug 31, 2027 NIH/Nat. Cancer Institute - Pass Through: Baylor College of Medicine U54 - Administrative Core Role: Principal Investigator |
| 1U54CA272691-02 (SHAUGHNESSY, JOHN)Sep 1, 2023 - Aug 31, 2027 NIH/Nat. Cancer Institute - Pass Through: Baylor College of Medicine U54 - Bioinformatics Core Role: Principal Investigator |
| R01CA115399 (TRICOT, GUIDO J.)Jul 13, 2006 - Apr 30, 2014 NIH Gene expression profiling vs MRD assessment in Myeloma Role: Co-Investigator |
| ZGEN TACI-Fc5 SRA (SHAUGHNESSY JR, JOHN)May 25, 2005 - May 25, 2007 ZymoGenetics, Inc Studying the role of APRIL and BAFF signaling in Myelomagenesis and its Therapy Role: Principal Investigator |
| ZGENTACI-Fc5SRA (SHAUGHNESSY JR, JOHN)May 25, 2005 - May 25, 2007 ZymoGenetics, Inc Studying the role of APRIL and BAFF signaling in Myelomagenesis and its Therapy Role: Principal Investigator |
| ARIA 15002 PcRA (SHAUGHNESSY JR, JOHN)Nov 3, 2004 - Sep 8, 2006 Millennium Pharmaceuticals, Inc. Preclinical Studies of the Mechanisms of Action of Velcade Role: Principal Investigator |
| ARIA15002PcRA (SHAUGHNESSY JR, JOHN)Nov 3, 2004 - Sep 8, 2006 Millennium Pharmaceuticals, Inc. Preclinical Studies of the Mechanisms of Action of Velcade Role: Principal Investigator |
| R33CA97513 (SHAUGHNESSY JR, JOHN)Jul 1, 2002 - Jun 30, 2005 NIH/Nat. Cancer Institute Molecular Diagnosis and Prognosis of Multiple Myeloma Role: Principal Investigator |
| R01CA093897 (YACCOBY, SHMUEL)Dec 1, 2001 - Nov 30, 2012 NIH Myeloma-Microenvironment Interaction Dynamics Role: Co-Investigator |
| U10CA32102 (SHAUGHNESSY JR, JOHN)Jan 1, 2001 - Dec 31, 2001 NIH/Nat. Cancer Institute Developmental Funds Pilot of the Southwest Oncology Group-SWOG-01047 Role: Principal Investigator |
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
Don't see publications published under other names? Login to add alternative names.
-
Cheng Y, Sun F, Alapat DV, Wanchai V, Mery D, Siegel ER, Xu H, Johnson S, Guo W, Bailey C, Ashby C, Bauer MA, Hadidi SA, Schinke C, Thanendrarajan S, Zangari M, van Rhee F, Tricot G, Shaughnessy JD, Zhan F. Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages. Blood Cancer J. 2024 11 06; 14(1):194. PMID: 39505839.
-
Guo W, Zhan Y, Mery D, Siegel ER, Sun F, Cheng Y, Ashby TC, Zhang Z, Bailey C, Alapat DV, Peng H, Hadidi SA, Thanendrarajan S, Schinke C, Zangari M, van Rhee F, Tricot G, Shaughnessy JD, Zhan F. Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems. Blood Cancer J. 2024 02 14; 14(1):30. PMID: 38355688.
-
Sun F, Cheng Y, Ying J, Mery D, Al Hadidi S, Wanchai V, Siegel ER, Xu H, Gai D, Ashby TC, Bailey C, Chen JR, Schinke C, Thanendrarajan S, Zangari M, Janz S, Barlogie B, Van Rhee F, Tricot G, Shaughnessy JD, Zhan F. A gene signature can predict risk of MGUS progressing to multiple myeloma. J Hematol Oncol. 2023 06 29; 16(1):70. PMID: 37386588.
-
Xiong W, Wu X, Starnes S, Johnson SK, Haessler J, Wang S, Chen L, Barlogie B, Shaughnessy JD, Zhan F. An analysis of the clinical and biological significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood. 2008.
-
Zhan F, Colla S, Wu X, Chen B, Stewart JP, Kuehl WM, Barlogie B, Shaughnessy JD. CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through. Blood. 2007; 109(11):4995 - 5001.
-
Santin AD, Zhan F, Bignotti E, Siegel ER, Cane S, Bellone S, Palmieri M, Anfossi S, Thomas M, Burnett A, Kay HH, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J, Pecorelli S. Gene expression profiles of primary H. Virology. 2005; 331(2):269 - 291.
-
Viera AJ, Hoag S, Shaughnessy J. Management of irritable bowel syndrome. Am Fam Physician. 2002; 66(10):1867 - 1874.
-
Groetsch SM, Shaughnessy JM. Medical management of acute appendicitis: a case report. J Am Board Fam Pract. 2001; 14(3):225 - 226.
-
Beecham EJ, Owens JD, Shaughnessy JD, Huppi K, Bohr VA, Mushinski JF. Decoupling of DNA excision repair and RNA transcription in translocation breaksite regions of plasmacytoma-susceptible BALB/cAnPt mice. Carcinogenesis. 1997; 18(4):687 - 694.
-
Shaughnessy J. Role of the manager with the injured worker. Innovative idea. AAOHN J. 1996; 44(10):505 - 506.
-
Janz S, Muller J, Shaughnessy J, Potter M. Detection of recombinations between c-myc and immunoglobulin switch alpha in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction. Proc Natl Acad Sci U S A. 1993; 90(15):7361 - 7365.
-
Shaughnessy J. Preventing slips, trips, and falls in the workplace. AAOHN J. 1993; 41(6):304 - 305.
-
Huppi K, Siwarski D, Shaughnessy J, Klemsz MJ, Shirakata M, Maki R, Sakano H. Genes associated with immunoglobulin V(D)J recombination are linked on mouse chromosome 2 and human chromosome 11. Immunogenetics. 1993; 37(4):288 - 291.
-
Shaughnessy JL. Legislative assistant spends day with public health nurses. Fla Nurse. 1992; 40(1):11, 13 - .
-
Grammer LC, Shaughnessy MA, Shaughnessy JJ, Patterson R. Safety and immunogenicity of immunotherapy with accelerated dosage schedules of polymerized grass and ragweed in patients with dual inhalant sensitivity. J Allergy Clin Immunol. 1989; 83(4):750 - 756.
-
Shaughnessy J, Mock B, Duncan R, Potter M, Banner C. A restriction fragment length polymorphism at murine Glud locus co-segregates with Rib-1, Es-10, and Tcra on chromosome 14. Nucleic Acids Res. 1989; 17(7):2881 - .
-
Grammer LC, Schafer M, Bernstein D, Bernstein IL, Cogen F, Dolovich J, Schatz M, Zeiger R, Shaughnessy JJ, Gutt L, . Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing. Clin Orthop Relat Res. 1988; (234):12 - 15.
-
Shaughnessy J. Pre-retirement planning and the role of the occupational health nurse. AAOHN J. 1988; 36(2):70 - 77.
-
Fidler JR, Zechmeister EB, Shaughnessy JJ. Memory for frequency of hearing popular songs. Am J Psychol. 1988; 101(1):31 - 49.
-
Grammer LC, Schafer M, Bernstein D, Bernstein IL, Dolovich J, Schatz M, Zeiger R, Cogen F, Shaughnessy JJ, Chandler MJ, . Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing. A preliminary report. Clin Orthop Relat Res. 1987; (221):202 - 206.
-
Grammer LC, Shaughnessy MA, Shaughnessy JJ, Patterson R. Practices in cat and dog immunotherapy among allergists. N Engl Reg Allergy Proc. 1987; 8(4):253 - 258.
-
Grammer LC, Shaughnessy MA, Finkle SM, Shaughnessy JJ, Patterson R. A double-blind placebo-controlled trial of polymerized whole grass administered in an accelerated dosage schedule for immunotherapy of grass pollinosis. J Allergy Clin Immunol. 1986; 78(6):1180 - 1184.
-
Neely CA, Truby SR, Shaughnessy JA, Barker ER, Burkhardt MA, Nagai-Jacobson MG, Snodgrass FG, Youngblood J. Professional role synthesis for nursing faculty: a redefinition of faculty practice. J Nurs Educ. 1986; 25(8):345 - 348.
-
Grammer LC, Shaughnessy MA, Finkle SM, Shaughnessy JJ, Patterson R. Safety and immunogenicity of immunotherapy with polymerized tree, grass, and ragweed in patients with multiple inhalant sensitivities. J Allergy Clin Immunol. 1986; 77(1 Pt 1):53 - 58.
-
Grammer LC, Shaughnessy MA, Shaughnessy JJ, Silvestri L, Patterson R. Allergenicity, immunogenicity, and safety of immunotherapy with various molecular weight ranges of polymerized ragweed. J Allergy Clin Immunol. 1985; 76(2 Pt 1):195 - 200.
-
Grammer LC, Shaughnessy MA, Shaughnessy JJ, Patterson R. Brief report: evaluation of polymerized ragweed extracts by intradermal end point titration, RAST inhibition, and parallel line bioassay. J Allergy Clin Immunol. 1985; 76(1):123 - 127.
-
Grammer LC, Shaughnessey MA, Shaughnessy JJ, Patterson R. Asthma as a variable in a study of immunotherapy for allergic rhinitis. J Allergy Clin Immunol. 1984; 73(5 Pt 1):557 - 560.
-
Grammer LC, Shaughnessy MA, Suszko IM, Shaughnessy JJ, Patterson R. Persistence of efficacy after a brief course of polymerized ragweed allergen: a controlled study. J Allergy Clin Immunol. 1984; 73(4):484 - 489.
-
Grammer LC, Shaughnessy MA, Suszko IM, Shaughnessy JJ, Patterson R. A double-blind histamine placebo-controlled trial of polymerized whole grass for immunotherapy of grass allergy. J Allergy Clin Immunol. 1983; 72(5 Pt 1):448 - 453.
-
Terhune JA, Shaughnessy J. Health skills for life. Health Educ. 1983; 14(5):27 - 31.
-
Shaughnessy JC. Central service catalog aids communication with nursing. HPN Hosp Purch News. 1982; 6(4):10 - .
-
Shaughnessy JP, Ferguson SJ, Harris DA, Radda GK. Interaction of mitochondrial adenosine triphosphatase with nucleotides and with glycerol [proceedings]. Biochem Soc Trans. 1977; 5(5):1539 - 1540.
-
Henshaw ET, Shaughnessy JT. The use of a scintillation counter to measure diagnostic X-ray tube kilovoltage, radiation exposure rates and contamination by low energy gamma emitters. Phys Med Biol. 1972; 17(4):577 - 583.
-
JURY B, SHAUGHNESSY JE. DIPLOMA PROGRAMS PROFIT THROUGH SHARING. Nurs Outlook. 1964; 12:50 - 51.
-
Shaughnessy J, Huppi, K., Mushinski, J.E. and Potter, M.. Springer-Verlag. Moloney Murine Leukemia Virus Integration 1060 Base Pairs 5' of c-Myc Exon 1 in a Plasmacytoma without a Chromosomal Translocation. Vol. 166 .
-
Shaughnessy jr. J. Current Topics in Microbiology and Immunology, Mechanisms in B-Cell Neoplasia. Chromosomal translocations t(12;15) are an early event in murine plasmacytomagenesis. pp. 303-309.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
1992 | 1 | 1993 | 3 | 1996 | 1 | 1997 | 1 | 2001 | 1 | 2002 | 1 | 2005 | 1 | 2007 | 1 | 2008 | 1 | 2023 | 1 | 2024 | 2 |
To return to the timeline, click here.
|
Shaughnessy Jr's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|